What does BioCrossroads invest in?
BioCrossroads invests most often at Series A and Seed (75% of the rounds on record), in sectors such as Logistics and Mobile.

United States · Investor
Last cheque observed Sep 2019. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.
QuietVC firm
7 rounds on record
Mostly Series A and Seed: 75% of its rounds
Sole investor in 3 rounds, median $293K
Every round we can evidence, newest first7 appearances
2 rounds
1 round
1 round
1 round
1 round
1 round
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
We hold 1 person at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
The latest companies BioCrossroads put money into.
BioCrossroads invests most often at Series A and Seed (75% of the rounds on record), in sectors such as Logistics and Mobile.
7 investments on record, 0 of them in the last 12 months. The most recent was in Sept 2019.
Its most recent investments on record: Sexton Biotechnologies (Undisclosed round, Sept 2019), Lumavate (Undisclosed round, Jun 2019) and Scioto (Series A, May 2018).
The median round it joins is $3.0M.
Rarely, if at all: none of its 7 investments on record names it as the lead.
Most of the companies it backs are in the United States (100%).
No investments in the last 12 months; the latest was in Sept 2019.
BioCrossroads is a VC firm based in Indianapolis, United States.
Find the investors who back rounds like yours, and keep every conversation on one fundraising board.
Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it